Brian Callaghan Selected Research

Selenium

1/2011

The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian Callaghan Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2013
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 11/2015
2	Neuralgia (Stump Neuralgia) 11/2022 - 01/2014
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2015 - 01/2014
1	Embolism (Embolus) 01/2021
1	Obesity 01/2021
1	COVID-19 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Acute Coronary Syndrome 01/2021
1	Stroke (Strokes) 05/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014
1	Pain (Aches) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013
1	Muscular Diseases (Myopathy) 08/2013
1	Drug Resistant Epilepsy 03/2011
1	Generalized Epilepsy 03/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2011

Drug/Important Bio-Agent (IBA)

3	NAD (NADH)IBA 01/2019 - 11/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 09/2013
1	SmokeIBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2020
1	Glucagon (Glukagon)FDA Link 11/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2015
1	Exenatide (Byetta)FDA Link 11/2015
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 08/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2011
1	SeleniumIBA 01/2011
1	MetalsIBA 01/2011
1	MercuryIBA 01/2011

Therapy/Procedure

2	Therapeutics 11/2022 - 01/2014
1	Percutaneous Coronary Intervention 05/2020
1	Thrombectomy 05/2020
1	Glycemic Control 01/2014